Phibro Animal Health Corporation Webcast and Conference Call August 29, 2024 U.S. toll-free +1.888.330.2022 International toll +1.365.977.0051 Conference ID: 3927884 Financial Results Fiscal Year 2024 Fourth Quarter Ended June 30, 2024 August 29, 2024 Webcast and Conference Call Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to any future debt and levera ...

Second quarter fiscal 2025 earnings August 29, 2024 Safe harbor 2 This presentation contains forward looking statements about revenue, billings, free cash flow, operating margin, EPS, products, future performance, financial and otherwise, and strategy, including statements regarding our progress on our key priorities, business models, guidance for the third fiscal quarter and full fiscal year 2025, and our longterm financial objectives. There are a significant number of factors that could cause actual resul ...

2Q24 Results Presentation August 29, 2024 CBOLCO 1 Forward looking statements 2 This presentation and any other written or oral statements made by us in connection with this presentation include forward-looking statements within the meaning of and made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities and events that will, should, could, are expected to or may occur in the future ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-----------------|-------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Second | | | | | | | | | | | | | | | | | August 28, 2024 | Quarter Earnings | | | | | | | | | | | | | | | | | | | | | | | | | Forward Looking Statements 2 • Safe Harbor Statement Under the Private Securities ...

mesoblast Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases ASX: MSB; Nasdaq: MESO Financial Results and Operational Update for the Year Ended June 30, 2024 August 2024 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achieveme ...

CROWDSTRIKE Financial Results Q2 FY 2025 ® CrowdStrike, Inc. All rights reserved. Safe Harbor This presentation includes express and implied "forward-looking statements", including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts, and in some cases, can be identified by terms such as "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," " ...

Data courtesy of Print my Leg Earnings Announcement August 28, 2024 | Q3 FY24 Forward-looking Statements This presentation contains forward-looking statements based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, they could affect the business and results of operations of HP Inc. and its consolidated subsidiaries ("HP") which may differ materially from those expressed orimplied by such forward-lo ...

| --- | --- | |--------------------------------|-------| | | | | | | | | | | Q2 FY25 Investor Presentation | | | August 28, 2024 | | Safe harbor This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our financial outlook, business strategy and plans, market trends and market size, opportunities and positioning. These forward-looking statements are b ...

| --- | --- | |-------|-------| | | | | | | | | | | | | Forward Looking Statements and Non-GAAP Information This presentation contains forward-looking statements regarding our products, business and operations, including but not limited to our views relating to future period financial and business results, demand for our products and subscription services, including Evergreen//One, our technology and product strategy, specifically customer priorities around sustainability, the environmental and energy savin ...

Q4 FY2024 Earnings August 28, 2024 Safe Harbor Non-GAAP Financial Measures and Other Key Performance Measures To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, this presentation includes the following non-GAAP financial and other key performance measures: non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, free cash flow, Annual Contract Value Billings (or ACV Billings), Annual Recurring Revenu ...